Tech Company Financing Transactions
Arsia Therapeutics Funding Round
Polaris Partners joined a $100 thousand venture round for Arsia Therapeutics. The funding round was announced on 12/31/2014.
Transaction Overview
Company Name
Announced On
12/31/2014
Transaction Type
Venture Equity
Amount
$100,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1000 Winter St. 3350
Waltham, MA 02451
USA
Waltham, MA 02451
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
Biologics are protein-based antibody drugs used to treat cancers, autoimmune disorders, and other chronic diseases. Comprised of very large molecules and typically delivered intravenously in high concentrations over several hours, these therapeutics are usually administered in hospitals settings or infusion clinics.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Co-Founder
Alan Crane
Co-Founder
Robert Langer
Browse more venture capital transactions:
Prev: 12/31/2014: RiskIQ venture capital transaction
Next: 12/31/2014: Ritter Pharmaceuticals venture capital transaction
Share this article
News on VC Transactions
We document tech company VC transactions. VC investment data records on this site are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs